Afuco™ Anti-Human GREM1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-GREM1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that bind to human gremlin-1 (GREM1 ) are used for treating a GREM1-related disease or disorder such as fibrosis and cancer.
Supplier Creative Biolabs
Product # AFC-318CL
Pricing Inquiry
Host Human
Target GREM1
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Feedback